Burosumab

X-linked Hypophosphatemia Disease Monitoring Program – (XLH-DMP)
To collect information on the long-term effects of XLH on children and adults who have participated in burosumab clinical trials, adults and children who have not participated in burosumab clinical trials, and who may or may not have been treated with burosumab during the course of the study
CHLA IRB Number
CHLA-18-00340
Study Type
Drug Treatment
Eligibility
Child, Adult, Older Adult X-linked Hypophosphatemia
Clinical Trials Government Identifier
NCT03651505
Enrollment Status
Open
Does this study also recruit healthy volunteers?
No
Coordinator Contact
Rebeca Martinez
Contact Email
rebmartinez@chla.usc.edu